share_log

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Tatsis Ourania

福泰製藥 | 4：持股變動聲明-高管 Tatsis Ourania

SEC announcement ·  02/28 06:10
牛牛AI助理已提取核心訊息
Ourania Tatsis, EVP, Chief Reg. & Quality Officer at Vertex Pharmaceuticals Inc. (VRTX), completed the sale of company shares on two separate dates. On February 23, 2024, Tatsis sold 3,309 shares of common stock at a price of $431.79 per share. Following this transaction, she disposed of an additional 354 shares on February 26, 2024, at a price of $425.70 per share. The total number of shares sold across both transactions was 3,663, resulting in a combined market value of approximately $1,579,490.91. After these sales, Tatsis directly holds 55,804 shares of Vertex Pharmaceuticals.
Ourania Tatsis, EVP, Chief Reg. & Quality Officer at Vertex Pharmaceuticals Inc. (VRTX), completed the sale of company shares on two separate dates. On February 23, 2024, Tatsis sold 3,309 shares of common stock at a price of $431.79 per share. Following this transaction, she disposed of an additional 354 shares on February 26, 2024, at a price of $425.70 per share. The total number of shares sold across both transactions was 3,663, resulting in a combined market value of approximately $1,579,490.91. After these sales, Tatsis directly holds 55,804 shares of Vertex Pharmaceuticals.
Vertex Pharmicals Inc.（VRTX）執行副總裁、首席註冊和質量官歐拉尼亞·塔西斯在兩個不同的日期完成了公司股票的出售。2024年2月23日，塔西斯以每股431.79美元的價格出售了3,309股普通股。在這筆交易之後，她於2024年2月26日以每股425.70美元的價格再出售了354股股票。兩筆交易中出售的股票總數爲3,663股，總市值約爲1,579,490.91美元。在這些出售之後，塔西斯直接持有Vertex Pharmicals的55,804股股票。
Vertex Pharmicals Inc.（VRTX）執行副總裁、首席註冊和質量官歐拉尼亞·塔西斯在兩個不同的日期完成了公司股票的出售。2024年2月23日，塔西斯以每股431.79美元的價格出售了3,309股普通股。在這筆交易之後，她於2024年2月26日以每股425.70美元的價格再出售了354股股票。兩筆交易中出售的股票總數爲3,663股，總市值約爲1,579,490.91美元。在這些出售之後，塔西斯直接持有Vertex Pharmicals的55,804股股票。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。